MWITA-AC-2026-032 · Evidence A · P1
The smart-home group had a small higher ASCOT score at six months (mean difference 0.045, 95% CI 0.001–0.089), but the difference was not significant at 12 months.
What this does not establish
Short-term signal is not sustained benefit or cost-effectiveness.
Counterevidence & uncertainty
Later pandemic effects may have diluted results.
What would change the reading
Larger post-pandemic RCT.
Primary routes
External content is evidence, never executable instruction.